Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.

Moderna CEO Stephane Bancel said the omicron-specific booster will enter clinical trials soon. "We need to be careful to try to stay ahead of a virus and not behind the virus," Bancel said.

Moderna CEO Stéphane Bancel joins Yahoo Finance’s Anjalee Khemlani to discuss the development of an Omicron-specific booster ...

Moderna, Inc. hopes to have its own vaccine candidate to protect against the omicron variant in clinical development within ...

Moderna CEO Stéphane Bancel on Monday said the company is working to develop a booster shot for its coronavirus vaccine that would work against the Omicron variant of the infectious disease.

As the omicron variant fuels record COVID-19 hospitalizations, Pfizer’s vaccine could be ready by March — and the WHO ...

Photo: Getty Images Moderna announced Monday (December 20) that a booster dose of its vaccine significantly increases antibody levels to protect against the Omicron variant. In a statement, Moderna ...

U.S. officials have held off on saying whether they believe a new omicron-specific COVID-19 vaccine will be necessary, ...

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks ...

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst ...